You can buy or sell FLXN and other stocks, options, ETFs, and crypto commission-free!
Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. Read More It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. The listed name for FLXN is Flexion Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours